JP7655885B2 - 脂肪族酸アミド誘導体を含有する医薬組成物 - Google Patents
脂肪族酸アミド誘導体を含有する医薬組成物 Download PDFInfo
- Publication number
- JP7655885B2 JP7655885B2 JP2022104196A JP2022104196A JP7655885B2 JP 7655885 B2 JP7655885 B2 JP 7655885B2 JP 2022104196 A JP2022104196 A JP 2022104196A JP 2022104196 A JP2022104196 A JP 2022104196A JP 7655885 B2 JP7655885 B2 JP 7655885B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- disorder
- pharmaceutical composition
- hydrogen atom
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021108402 | 2021-06-30 | ||
| JP2021108402 | 2021-06-30 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023008912A JP2023008912A (ja) | 2023-01-19 |
| JP2023008912A5 JP2023008912A5 (https=) | 2023-12-12 |
| JP7655885B2 true JP7655885B2 (ja) | 2025-04-02 |
Family
ID=85112098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022104196A Active JP7655885B2 (ja) | 2021-06-30 | 2022-06-29 | 脂肪族酸アミド誘導体を含有する医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7655885B2 (https=) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006508101A (ja) | 2002-11-08 | 2006-03-09 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | フェニルアルキルおよびピリジルアルキルピペラジン誘導体 |
| JP2008539268A (ja) | 2005-04-26 | 2008-11-13 | ハイプニオン・インコーポレイテッド | ベンズイソオキサゾールピペラジン化合物およびその使用方法 |
| JP2013522165A (ja) | 2010-03-11 | 2013-06-13 | 大日本住友製薬株式会社 | Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩 |
| WO2021132311A1 (ja) | 2019-12-24 | 2021-07-01 | 大日本住友製薬株式会社 | 脂肪族酸アミド誘導体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
| EP0732332B1 (en) * | 1995-03-17 | 2001-12-19 | Aventis Pharmaceuticals Inc. | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation |
-
2022
- 2022-06-29 JP JP2022104196A patent/JP7655885B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006508101A (ja) | 2002-11-08 | 2006-03-09 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | フェニルアルキルおよびピリジルアルキルピペラジン誘導体 |
| JP2008539268A (ja) | 2005-04-26 | 2008-11-13 | ハイプニオン・インコーポレイテッド | ベンズイソオキサゾールピペラジン化合物およびその使用方法 |
| JP2013522165A (ja) | 2010-03-11 | 2013-06-13 | 大日本住友製薬株式会社 | Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩 |
| WO2021132311A1 (ja) | 2019-12-24 | 2021-07-01 | 大日本住友製薬株式会社 | 脂肪族酸アミド誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023008912A (ja) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2957046C (en) | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | |
| TW202134229A (zh) | 環烷基尿素衍生物 | |
| CN103917534B (zh) | 作为h3受体抑制剂的包含哌啶和哌嗪环的氨基甲酸酯/脲衍生物 | |
| US20260078115A1 (en) | Aliphatic acid amide derivative | |
| CA2878006C (en) | Carbamate/urea derivatives | |
| IL291774A (en) | Compounds active towards nuclear receptors | |
| JP7097342B2 (ja) | ２，６－ジ置換ピリジン誘導体 | |
| JP7655885B2 (ja) | 脂肪族酸アミド誘導体を含有する医薬組成物 | |
| TWI917344B (zh) | 脂肪族酸醯胺衍生物 | |
| BRPI0710792A2 (pt) | composto, medicamento, composição farmacêutica, preparação farmacêutica combinada, uso de um composto, uso de uma preparação combinada, e, processo para a preparaçáo dos compostos. | |
| CA3199269A1 (en) | Isoxazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
| HK40079616B (en) | Aliphatic acid amide derivative | |
| HK40079616A (en) | Aliphatic acid amide derivative | |
| EA046822B1 (ru) | Производное амида алифатической кислоты | |
| BR112017005241B1 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| JP7382188B2 (ja) | ２，６－ジ置換ピリジン誘導体からなる医薬 | |
| WO2019146740A1 (ja) | ドーパミンｄ３受容体拮抗作用を有する環式化合物 | |
| JP2011524351A (ja) | Ｃｂ１アンタゴニスト活性を有するフルオロ置換された３，４−ジアリール−４，５−ジヒドロ−１ｈ−ピラゾール−１−カルボキサミジン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231201 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231201 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20241115 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241217 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250108 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250305 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250321 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7655885 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |